How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Oncogene Année : 2014

How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Résumé

Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-3-phosphate dehydrogenase activate survival pathways (Akt and so on); phosphofructokinase 1 and triose phosphate isomerase participate in cell cycle activation; aldolase promotes epithelial mesenchymal transition; PKM2 enhances various nuclear effects such as transcription, stabilisation and so on. This review outlines the multiple non-glycolytic roles of glycolytic enzymes, which are essential for promoting cancer cells' survival, proliferation, chemoresistance and dissemination.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-01427176 , version 1 (05-01-2017)

Identifiants

Citer

Hubert Lincet, Philippe Icard. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?. Oncogene, 2014, 34 (29), pp.3751 - 3759. ⟨10.1038/onc.2014.320⟩. ⟨inserm-01427176⟩
897 Consultations
16 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More